China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.82	8.17	22.7	3.33	1.85	9.93
Short-Term Investments	84.88	-	-	-	-	-
Cash & Short-Term Investments	86.7	8.17	22.7	3.33	1.85	9.93
Cash Growth	1090.54%	-64.02%	580.92%	80.31%	-81.38%	108.29%
Accounts Receivable	5.28	5.1	0.62	1.2	0.07	0.21
Other Receivables	-	52.98	28.02	156.43	237.71	196.91
Receivables	5.28	58.08	28.64	157.63	237.78	197.12
Inventory	2.61	2.03	0.24	0.45	0.29	0.38
Prepaid Expenses	-	0.26	0.16	0.19	2.56	41.36
Other Current Assets	-	17.5	6.58	6.99	6.62	9.59
Total Current Assets	94.59	86.04	58.31	168.58	249.09	258.39
Property, Plant & Equipment	18.5	23.14	6.99	17.32	26.82	0.75
Other Long-Term Assets	30.14	58.88	70.41	-	-	-
Total Assets	143.24	168.06	135.71	185.9	275.91	259.14

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.35	3	3.84	2.47	0.05	0.09
Accrued Expenses	17.1	4.24	8.67	13.11	7.65	3.71
Current Portion of Long-Term Debt	3.63	3.63	3.63	13.63	48.41	29.95
Current Portion of Leases	8.68	8.46	4.59	10.4	9.92	5.87
Current Income Taxes Payable	13.71	13.17	24.87	25.29	25.57	24.26
Current Unearned Revenue	12.92	26.66	11.29	81.09	60.74	76.6
Other Current Liabilities	-	16.06	1.98	1.81	5.82	6.83
Total Current Liabilities	60.39	75.23	58.87	147.79	158.17	147.31
Long-Term Debt	17.6	26.48	45.47	21.58	-	-
Long-Term Leases	8.34	12.74	-	4.59	13.68	-
Long-Term Deferred Tax Liabilities	0.15	0.15	0.15	0.15	0.15	0.1
Other Long-Term Liabilities	-	-	6.02	-	-	-
Total Liabilities	86.48	114.59	110.51	174.1	172	147.41

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	60.85	60.85	60.85	60.85	570.86	570.86
Additional Paid-In Capital	3,216	3,216	3,216	3,216	3,204	3,204
Retained Earnings	-2,790	-2,795	-2,863	-2,881	-3,287	-3,292
Comprehensive Income & Other	-429.43	-428.09	-388.23	-383.88	-383.46	-371.09
Total Common Equity	56.76	53.47	25.2	11.79	103.92	111.73
Shareholders' Equity	56.76	53.47	25.2	11.79	103.92	111.73
Total Liabilities & Equity	143.24	168.06	135.71	185.9	275.91	259.14

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	38.25	51.31	53.69	50.19	72.01	35.82
Net Cash (Debt)	48.45	-43.14	-30.99	-46.86	-70.16	-25.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.16	-0.14	-0.10	-0.16	-0.25	-0.09
Filing Date Shares Outstanding	304.25	304.25	304.25	304.25	285.43	285.43
Total Common Shares Outstanding	304.25	304.25	304.25	304.25	285.43	285.43
Working Capital	34.2	10.81	-0.56	20.79	90.93	111.08
Book Value Per Share	0.19	0.18	0.08	0.04	0.36	0.39
Tangible Book Value	56.76	53.47	25.2	11.79	103.92	111.73
Tangible Book Value Per Share	0.19	0.18	0.08	0.04	0.36	0.39
Machinery	-	7.38	6.44	6.47	53.66	53.4
Leasehold Improvements	-	22.19	22.19	21.74	104.15	101.82

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error